Prot #VX20-121-104: A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis

Project: Research project

Project Details

StatusActive
Effective start/end date3/28/233/28/26

Funding

  • Vertex Pharmaceuticals Incorporated (Prot #VX20-121-104 AMD 1)